Metrikler
Yayın
83
Açık Erişim
7
BM Sürdürülebilir Kalkınma Amaçları
Eğitim Bilgileri
1995 - 1997
1995 - 1997Tıpta Yandal Uzmanlık
Marmara Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Türkiye
1989 - 1994
1989 - 1994Tıpta Uzmanlık
Marmara Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Türkiye
1983 - 1989
1983 - 1989Lisans
Hacettepe Üniversitesi, Tıp Fakültesi, Tıp Pr., Türkiye
Araştırma Alanları
Sağlık Bilimleri
Akademik Ünvanlar / Görevler
2010 - Devam Ediyor
2010 - Devam EdiyorProf. Dr.
Marmara Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
2004 - 2009
2004 - 2009Doç. Dr.
Marmara Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
Yönetimsel Görevler
2011 - 2020
2011 - 2020Bölüm Başkanı
Marmara Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
Akademi Dışı Deneyim
2010 - Devam Ediyor
2010 - Devam Ediyoröğretim üyesi profesör
marmara üniversitesi , öğretim üyesi profesör
2004 - 2009
2004 - 2009öğretim üyesi doçent
marmara üniversitesi , öğretim üyesi doçent
2002 - 2004
2002 - 2004öğretim görevlisi
marmara üniversitesi , öğretim görevlisi
2001 - 2002
2001 - 2002araştırma asistanı
Barcelona Üniversitesi, araştırma asistanı
1998 - 1999
1998 - 1999yedek subay uzman doktor
Haydarpaşa GATA, yedek subay uzman doktor
1994 - 1997
1994 - 1997Gastroenteroloji yan dal asistanlığı
marmara üniversitesi tıp fakültesi , Gastroenteroloji yan dal asistanlığı
1989 - 1994
1989 - 1994İç Hastalıkları asistanlığı
marmara üniversitesi tıp fakültesi , İç Hastalıkları asistanlığı
Yönetilen Tezler
Devam Ediyor
Devam EdiyorHepatosellüler karsinomda (HCC) prognoza etki eden faktörler
ÖZDOĞAN O. C. (Danışman)
A.Syıkymbayev(Öğrenci)
2015
2015Tıpta Uzmanlık
Karaciğer fibrozisinin değerlendirilmesinde non-invaziv yöntemlerin önemi
ÖZDOĞAN O. C. (Danışman)
S.Sertaç(Öğrenci)
Makaleler
Tümü (66)
SCI-E, SSCI, AHCI (56)
SCI-E, SSCI, AHCI, ESCI (63)
ESCI (7)
Scopus (65)
TRDizin (21)
Diğer Yayınlar (1)
2025
20251. BALAD-2 Emerges as the Most Accurate Prognostic Model in Hepatocellular Carcinoma: Results from a Biobank-Based Cohort Study
DEMİRTAŞ C. Ö., EREN F., YILMAZ KARADAĞ D., Kaldirim Armutcuoglu Y., Tolu T., Huseyinov J., et al.
Cancers
, cilt.17, sa.21, 2025 (SCI-Expanded, Scopus)
2025
20252. Enhancing Hepatocellular Carcinoma Surveillance: Comparative Evaluation of AFP, AFP-L3, DCP and Composite Models in a Biobank-Based Case-Control Study
DEMİRTAŞ C. Ö., AKIN Ş., YILMAZ KARADAĞ D., YILMAZ İ. T., Ciftci U., Huseynov J., et al.
Cancers
, cilt.17, sa.14, 2025 (SCI-Expanded)
2025
20253. Usefulness of Endoscopic Ultrasound Strain Elastography for Measuring Liver Stiffness and the Role of Blood Cytokeratin 18 Levels as a Surrogate Marker of Fibrosis
Duman D. G., Alahdab Y. O., DEMİRTAŞ C. Ö., YILMAZ Y., DİLBER F., Ozdemir F. T., et al.
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
, cilt.36, sa.10, ss.692-699, 2025 (SCI-Expanded, Scopus, TRDizin)
2024
20244. The impact of an education program on the appropriate prescription of proton pump inhibitors in hospitalized internal medicine services patients
AYHAN Y. E., ENVER C., OKUYAN B., KEKLİKKIRAN Ç., Azizy A., Yolcu T. K., et al.
Acta Pharmaceutica Sciencia
, cilt.62, sa.1, ss.145-158, 2024 (Scopus)
2023
20235. Evaluation of the effectiveness of drug-eluting transarterial chemoebolization in hepatocellular carcinoma
ALAN A. M., ALAN Ö., ASADOV R., DEMİRTAŞ C. Ö., KANİ H. T., YUMUK P. F., et al.
Hepatology forum
, cilt.4, sa.2, ss.53-60, 2023 (Scopus)
2022
20226. Practicality and potential restrictions of unresectable hepatocellular carcinoma prognostic index
DEMİRTAŞ C. Ö., Ricco G., ÖZDOĞAN O. C., BALTACIOĞLU F., ÖNEŞ T., YUMUK P. F., et al.
HEPATOLOGY COMMUNICATIONS
, cilt.6, sa.12, ss.3600-3601, 2022 (SCI-Expanded)
2022
20227. Characteristics of patients with hepatocellular carcinoma: A multicenter study
Guzelbulut F., KARAOĞULLARINDAN Ü., AKKIZ H., ALTINTAŞ E., DEMİRTAŞ C. Ö., Bahadir O., et al.
HEPATOLOGY FORUM
, cilt.3, sa.3, ss.71-76, 2022 (ESCI)
2022
20228. Palliative care in cirrhotic patients: Brief summary of recent AASLD guidance
ÖZDOĞAN O. C.
HEPATOLOGY FORUM
, cilt.3, sa.3, ss.100-102, 2022 (ESCI)
2022
20229. Proposal and Validation of a Novel Scoring System for Hepatocellular Carcinomas Beyond Curability Borders
DEMİRTAŞ C. Ö., Ricco G., ÖZDOĞAN O. C., BALTACIOĞLU F., Ones T., YUMUK P. F., et al.
HEPATOLOGY COMMUNICATIONS
, cilt.6, sa.3, ss.633-645, 2022 (SCI-Expanded)
2022
202210. Mutation Spectrum of Familial Adenomatous Polyposis Patients in Turkish Population: Identification of 3 Novel APC Mutations
Ates E. A., ALAVANDA C., Demir S., KEKLİKKIRAN Ç., Attaallah W., ÖZDOĞAN O. C., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.33, sa.2, ss.81-87, 2022 (SCI-Expanded)
2021
202111. Surveillance Strategies for Hepatocellular Carcinoma: Recent Advances and the Shifting Paradigm
DEMİRTAŞ C. Ö., GÜNDÜZ F., ÖZDOĞAN O. C.
JOURNAL OF GASTROINTESTINAL CANCER
, cilt.52, sa.4, ss.1336-1339, 2021 (ESCI)
2021
202112. Hepatocellular Carcinoma in Non-cirrhotic Liver Arises with a More Advanced Tumoral Appearance: A Single-Center Cohort Study
DEMİRTAŞ C. Ö., Tolu T., KEKLİKKIRAN Ç., ÖZDOĞAN O. C., GÜNDÜZ F.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.32, sa.8, ss.685-693, 2021 (SCI-Expanded)
2021
202113. Proposal and validation of a novel scoring system for hepatocellular carcinomas beyond curability borders: Unresectable hepatocellular carcinoma prognostic index
DEMİRTAŞ C. Ö., Ricco G., ÖZDOĞAN O. C., BALTACIOĞLU F., ÖNEŞ T., YUMUK P. F., et al.
JOURNAL OF HEPATOLOGY
, cilt.75, 2021 (SCI-Expanded)
2021
202114. Etiology of Cirrhosis in Turkey: A National Cohort Study
YILDIRIM A. E., ÜÇBİLEK E., Oruncu M. B., TURAN İ., DEMİR M., Koksal A., et al.
JOURNAL OF HEPATOLOGY
, cilt.75, 2021 (SCI-Expanded)
2021
202115. PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis
Trebicka J., Fernandez J., Papp M., Caraceni P., Laleman W., Gambino C., et al.
JOURNAL OF HEPATOLOGY
, cilt.74, sa.5, ss.1097-1108, 2021 (SCI-Expanded)
2021
202116. Recommendations for Reopening Endoscopy Units in Turkey: A Set-up Plan from a Tertiary Center in Istanbul.
Demirtas C. Ö., Keklikkıran Ç., Mehdiyev S., Ergenç İ., Özen Alahdab Y., Gündüz F., et al.
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
, cilt.32, ss.113-115, 2021 (SCI-Expanded)
2020
202017. Evaluation of the Association between Programmed Cell Death-1 Gene Polymorphisms and Hepatocellular Carcinoma Susceptibility in Turkish Subjects. A Pilot Study
Demirci A. F., Demirtas C. O., Eren F., Yilmaz D., Keklikkiran C., Ozdogan O. C., et al.
JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES
, cilt.29, sa.4, ss.617-622, 2020 (SCI-Expanded, Scopus)
2020
202018. No Association Between Programmed Cell Death-1 Gene Polymorphisms and Hepatocellular Carcinoma Susceptibility in Turkish Subjects
Demirci A. F., Demirtaş C. Ö., Eren F., Yılmaz D., Keklikkıran Ç., Özdoğan O. C., et al.
Journal Of Gastrointestinal And Liver Diseases , cilt.1, ss.1-2, 2020 (SCI-Expanded, Scopus)
2020
202019. Surveillance of hepatocellular carcinoma in cirrhotic patients: Current knowledge and future directions
Demirtas C. O., ÖZDOĞAN O. C.
HEPATOLOGY FORUM
, cilt.1, sa.3, ss.112-118, 2020 (ESCI)
2020
202020. The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology
Trebicka J., Fernandez J., Papp M., Caraceni P., Laleman W., Gambino C., et al.
JOURNAL OF HEPATOLOGY
, cilt.73, ss.842-854, 2020 (SCI-Expanded)
2020
202021. External validation of the Toronto hepatocellular carcinoma risk index in Turkish cirrhotic patients.
Demirtas C., Gunduz F., Kani H. T., Keklikkıran C., Alahdab Y., Yılmaz Y., et al.
European journal of gastroenterology & hepatology
, cilt.32, sa.7, ss.882-888, 2020 (SCI-Expanded)
2020
202022. Annual contrast-enhanced magnetic resonance imaging is highly effective in the surveillance of hepatocellular carcinoma among cirrhotic patients
Demirtas C., Gunduz F., Tuney D., Baltacioglu F., Kani H. T., Bugdayci O., et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
, cilt.32, sa.4, ss.517-523, 2020 (SCI-Expanded)
2019
201923. Appraising diagnostic performance of ELF test by pathological staging and digital quantification of liver fibrosis
Gunes Y., Durusoy S., Ture O., Kombak E., Ataizi-Celikel Ç., Ozdogan O. C.
ANNALS OF HEPATOLOGY
, cilt.18, sa.6, ss.833-840, 2019 (SCI-Expanded)
2019
201924. Evaluation of depression, anxiety and quality of life in hepatitis C patients who treated with direct acting antiviral agents
Kesen O., Kani H. T., Yanartaş Ö., Aykut U., Gök B., Gündüz F., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.30, sa.9, ss.801-806, 2019 (SCI-Expanded)
2019
201925. From the Editor
Ozdogan O. C.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.30, sa.7, 2019 (SCI-Expanded)
2019
201926. Thermal ablation of mucosal defect margins reduces adenoma recurrence after colonic endoscopic mucosal resection.
Keklikkıran Ç., Özdoğan O. C.
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
, cilt.30, ss.580-581, 2019 (SCI-Expanded)
2019
201927. Mesenchymal stem cells suppress hepatic fibrosis accompanied by expanded intrahepatic natural killer cells in rat fibrosis model
Duman D., Zibandeh N., Ugurlu M. Ü., Celikel Ç., Akkoc T., Banzragch M., et al.
MOLECULAR BIOLOGY REPORTS
, cilt.46, sa.3, ss.2997-3008, 2019 (SCI-Expanded)
2018
201828. Convenient chronic hepatitis B candidates for antiviral cessation and retreatment after relapse: When and who?
DEMİRTAŞ C. Ö., ÖZDOĞAN O. C.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.29, sa.6, ss.720-721, 2018 (SCI-Expanded)
2017
201729. Turkey 2017 Clinical Practice Guidelines on recommendations for screening diagnosing and managing hepatitis C virus.
Idilman R., Baykam N., Kaymakoğlu S., Tabak F., Bahçecioğlu H., Bektaş A., et al.
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
, cilt.28, ss.90-93, 2017 (SCI-Expanded)
2017
201730. Platelet Count/Spleen Diameter Ratio and Shear-Wave Elastography for Non-Invasive Prediction of High- Risk Varices: Can We Delay Screening Endoscopy for Compensated Cirrhosis?
Yegin E. G., Karatay E., Celik G., ALDAĞ B., TÜNEY D., ÖZDOĞAN O. C.
HEPATITIS MONTHLY
, cilt.17, sa.12, 2017 (SCI-Expanded)
2017
201731. From the Editor
Ozdogan O. C.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.28, sa.6, ss.428, 2017 (SCI-Expanded)
2017
201732. From the Editor
Ozdogan O. C.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.28, sa.4, 2017 (SCI-Expanded)
2017
201733. From the Editor
Ozdogan O. C.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.28, sa.2, 2017 (SCI-Expanded)
2017
201734. From the Editor
Ozdogan O. C.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.28, sa.1, 2017 (SCI-Expanded)
2016
201635. Digital image analysis in liver fibrosis: basic requirements and clinical implementation
Yegin E. G., YEĞİN K., ÖZDOĞAN O. C.
BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT
, cilt.30, sa.4, ss.653-660, 2016 (SCI-Expanded)
2016
201636. Empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: Should we start direct broader-spectrum antibiotics or not?
ÖZDOĞAN O. C.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.27, sa.3, ss.294-295, 2016 (SCI-Expanded)
2016
201637. New developments in the era of viral hepatitis vaccines
Poyraz M., ÖZDOĞAN O. C.
MARMARA MEDICAL JOURNAL
, cilt.29, ss.29-32, 2016 (ESCI)
2015
201538. Seroprevalence of hepatitis B and C virus infections and risk factors in Turkey: a fieldwork TURHEP study
Tozun N., Ozdogan O. C., Cakaloglu Y., Idilman R., Karasu Z., Akarca U., et al.
CLINICAL MICROBIOLOGY AND INFECTION
, cilt.21, sa.11, ss.1020-1026, 2015 (SCI-Expanded)
2015
201539. Impact of Education Provided by Nurses on Quality of Life, Anxiety, and Depression in Patients Receiving Hepatitis C Virus Therapy
Cinar S., ÖZDOĞAN O. C., ÖZEN ALAHDAB Y.
GASTROENTEROLOGY NURSING
, cilt.38, sa.5, ss.343-347, 2015 (SCI-Expanded)
2015
201540. Quantitative assessment of liver fibrosis by digital image analysis: Relationship to Ishak staging and elasticity by shear-wave elastography
Yegin E. G., YEĞİN K., Karatay E., Kombak E. F., TÜNEY D., Ataizi-Celikel Ç., et al.
JOURNAL OF DIGESTIVE DISEASES
, cilt.16, sa.4, ss.217-227, 2015 (SCI-Expanded)
2014
201441. Partial virological response to three different nucleotide analogues in naive patients with chronic hepatitis B
Yegin E. G., ÖZDOĞAN O. C.
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL
, cilt.13, sa.6, ss.602-611, 2014 (SCI-Expanded)
2014
201442. Decision-making dilemma in drug-induced acute pancreatitis
Yegin E. G., Eryuksel E., GİRAL A., CEYHAN B., ÖZDOĞAN O. C.
JOURNAL OF DIGESTIVE DISEASES
, cilt.15, sa.12, ss.694-697, 2014 (SCI-Expanded)
2014
201443. The association between insulin resistance and hepatic fibrosis in patients with chronic hepatitis C: An observational, multicenter study in Turkey
Dokmeci A., ÜSTÜNDAĞ Y., Hulagu S., Tuncer I., Akdogan M., Demirsoy H., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.25, sa.5, ss.546-552, 2014 (SCI-Expanded)
2014
201444. Esophageal perforation: A rare but fatal complication of urgent sengstaken blakemore tube intubation Özofagus perforasyonu: Acil sengstaken blakemore tüp kullani{dotless}mi{dotless} sonrasi{dotless} gelişen nadir fakat ölümcül komplikasyon
Akbaş T., Bilgin H., Yeǧin E. G., ÇİMŞİT N. Ç., ÖZDOĞAN O. C., KARAKURT S.
Journal of Medical and Surgical Intensive Care Medicine
, cilt.4, sa.2, ss.28-31, 2014 (ESCI)
2013
201345. Prognostic implication of serum vascular endothelial growth factor in advanced hepatocellular carcinoma staging
Yegin E. G., Siykhynnbayev A., EREN F., Bekiroglu N., ÖZDOĞAN O. C.
ANNALS OF HEPATOLOGY
, cilt.12, sa.6, ss.915-925, 2013 (SCI-Expanded)
2012
201246. Esophageal Perforation A Rare but Fatal Complication of Urgent Sengstaken Blakemore Tube Intubation
AKBAŞ T., BİLGİN H., GÜNEŞ YEĞİN E., Cimşit N. Ç., ÖZDOĞAN O. C., KARAKURT S.
Journal of Medical and Surgical Intensive Care Medicine , 2012 (ESCI)
2010
201047. The prevalence of the mutation in codon 249 of the P53 gene in patients with hepatocellular carcinoma (HCC) in Turkey.
Ozdemir F., Tiftikci A., Sancak S., Eren F., Tahan V., Akın H., et al.
Journal of gastrointestinal cancer
, cilt.41, ss.185-9, 2010 (SCI-Expanded, Scopus)
2009
200948. Non-alcoholic fatty liver disease and microalbuminuria in non-diabetic patients: Role of insulin resistance
Yılmaz Y., Alahdab Y., Özdoğan O. C., Dolar E.
Internal Medicine Journal
, cilt.39, ss.709-710, 2009 (SCI-Expanded)
2009
200949. Cytokeratin-18 fragments and biomarkers of the metabolic syndrome in nonalcoholic steatohepatitis.
YILMAZ Y., Kedrah A. E., Ozdogan O. C.
World journal of gastroenterology
, cilt.15, sa.35, ss.4387-91, 2009 (SCI-Expanded)
2009
200950. Interstitial pneumonitis associated with pegylated interferon-alpha 2a and ribavirin for chronic hepatitis C infection: a case report.
Atug O., Akin H., Alahdab Y., Ceyhan B., Tozun N., Ozdogan O. C.
Cases journal
, cilt.2, ss.6464, 2009 (Hakemli Dergi)
2005
200551. Determination of hepatitis B genotypes in patients with chronic hepatitis B virus infection in Turkey.
Ozdemir F., Duman D., Ertem D., Avşar E., Eren F., Ozdoğan O. C., et al.
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
, cilt.16, ss.183-7, 2005 (SCI-Expanded, Scopus, TRDizin)
2005
200552. Impact of Helicobacter pylori eradication on the anti-secretory efficacy of lansoprazole in gastroesophageal reflux disease patients
Giral A., Celikel Ç., Ozdogan O. C., Tozun N., Ulusoy N., Kalayci C.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
, cilt.20, sa.12, ss.1886-1891, 2005 (SCI-Expanded)
2005
200553. MELD score and clinical type predict prognosis in hepatorenal syndrome: Relevance to liver transplantation
Alessandria C., Ozdogan O. C., Guevara M., Restuccia T., Jimenez W., Arroyo V., et al.
HEPATOLOGY
, cilt.41, sa.6, ss.1282-1289, 2005 (SCI-Expanded)
2005
200554. Octreotide in liver cirrhosis: a salvage for variceal bleeding can be a gunshot for kidneys
Duman D., Tuney D., Bilsel S., Benli F., Karan S., Avsar E., et al.
LIVER INTERNATIONAL
, cilt.25, sa.3, ss.527-535, 2005 (SCI-Expanded)
2005
200555. Measurement of hepatic venous pressure gradient in patients with active variceal bleeding.
Ozdogan O. C.
Hepatology (Baltimore, Md.)
, cilt.41, sa.2, 2005 (SCI-Expanded)
2004
200456. Prevalence of hepatic granulomas in chronic hepatitis B
Tahan V., Ozaras R., Lacevic N., Ozden E., Yemisen M., Ozdogan O. C., et al.
DIGESTIVE DISEASES AND SCIENCES
, cilt.49, sa.10, ss.1575-1577, 2004 (SCI-Expanded)
2004
200457. Effect of Helicobacter pylori eradication on anti-thrombotic dose aspirin-induced gastroduodenal mucosal injury
Giral A., Ozdogan O. C., Celikel Ç., Tozun N., Ulusoy N., Kalayci C.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
, cilt.19, sa.7, ss.773-777, 2004 (SCI-Expanded)
2004
200458. Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome. A case-control study
Restuccia T., Ortega R., Guevara M., Gines P., Alessandria C., Ozdogan O. C., et al.
JOURNAL OF HEPATOLOGY
, cilt.40, sa.1, ss.140-146, 2004 (SCI-Expanded)
2004
200459. Anti-HCV seroprevalence in chronic HCV patients' children in Turkey
Tahan V., Yildirim B., Ture F., Giral A., Ozdogan O. C., Imeryuz N., et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY
, cilt.38, sa.1, ss.90-91, 2004 (SCI-Expanded)
2003
200360. Causes and risk factors for liver injury following bone marrow transplantation
Ozdogan O. C., Ratip S., Al Ahdab Y., Dane F., Al Ahdab H., Imeryuz N., et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY
, cilt.36, sa.5, ss.421-426, 2003 (SCI-Expanded)
2003
200361. In vivo inefficiency of pentoxifylline and interferon-alpha on hepatic fibrosis in biliary-obstructed rats: assessment by tissue collagen content and prolidase activity.
Tarcin O., Avsar K., Demirturk L., Gultepe M., Oktar B., Ozdogan O. C., et al.
Journal of gastroenterology and hepatology
, cilt.18, sa.4, ss.437-44, 2003 (SCI-Expanded)
2002
200262. Role of endothelin-1 in a cirrhotic rat model with endotoxin induced acute renal failure
Ozdogan O. C., Goren M., Ratip S., Giral A., Moini H., Enc F., et al.
HEPATOLOGY RESEARCH
, cilt.24, sa.2, ss.114-124, 2002 (SCI-Expanded)
1999
199963. The effect of hyperbaric oxygen therapy on TNBS-E colitis in rats
Hamzaoglu H., Alican I., Kurtkaya O., Elbuken E., Avsar E., Hamzaoglu I., et al.
GASTROENTEROLOGY
, cilt.116, sa.4, 1999 (SCI-Expanded)
1998
199864. Effect of intraluminal temperature on human oesophageal motor function
Ozdogan O. C., Saadalla A., Emironal G., Yegen B., Ulusoy N.
CLINICAL PHYSIOLOGY
, cilt.18, sa.6, ss.504-509, 1998 (SCI-Expanded)
1997
199765. Alteration of esophageal motility by intraluminal temperature OZOFAGUS MOTILITESININ LUMEN ICI SICAKLIGI ILE DEGISIMI
ÖZDOĞAN O. C., Sadallah A., Emironal G., YEGEN B., Ulusoy N.
Turkish Journal of Gastroenterology
, cilt.8, sa.1, ss.52-56, 1997 (SCI-Expanded)
1995
199566. TEMPERATURE-DEPENDENCE OF ESOPHAGEAL MOTOR FUNCTION IN MAN REVISITED
OZDOGAN O. C., SAADALLA A., EMIRONAL G., YEGEN B., ULUSOY N.
GASTROENTEROLOGY
, cilt.108, sa.4, 1995 (SCI-Expanded)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
2019
20191. Hepatoselüler Karsinomda Drug-Eluting-Transarteriyel Kemoembolizasyon (Deb-TAKE) Uygulamasının Etkinliğinin ve Güvenirliğinin Retrospektif Olarak Değerlendirilmesi
MÜTİŞ A., ALAN Ö., Asadov R., demirtaş ç. ö., KANİ H. T., YUMUK P. F., et al.
12. ULUSAL HEPATOLOJİ KONGRESİ, Antalya, Türkiye, 1 - 05 Mayıs 2019, (Tam Metin Bildiri)
2019
20192. Annual contrast-enhanced MRI is highly effective in the surveillance of hepatocellular carcinoma in cirrhotic patients
DEMİRTAŞ C. Ö., GÜNDÜZ F., TÜNEY D., BALTACIOĞLU F., ÖZEN ALAHDAB Y., ÖZDOĞAN O. C.
International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Vienna, Avusturya, 10 - 14 Nisan 2019, cilt.70, (Özet Bildiri)
2018
20183. ENDOSKOPİK RETROGRAD KOLANJİOPANKREATİKOGRAFİ (ERCP) SONRASI KOLESİSTEKTOMİ GEREKLİ MİDİR?
KARPUZ Ş., Coşkun M., ASADOV R., GİRAL A., ÖZDOĞAN O. C., ATALAY V.
21. ULUSAL CERRAHİ KONGRESİ, Türkiye, 11 - 15 Nisan 2018, (Özet Bildiri)
2015
20154. Sıçan Kemikiliği Kökenli Mezenkimal Kök Hücrelerin Koledok Bağlama Yöntemi ile Oluşturulmuş Hepatofibroz Modelinde İmmünoloji Parametreler Üzerine Tedavi Edici Etkisi
DUMAN D., Munktsetseg B., Noushin Z., UĞURLU M. Ü., Tolga A., Genç D., et al.
32. Ulusal Gastroenteroloji Kongresi, Türkiye, 25 - 29 Kasım 2015, (Özet Bildiri)
2015
20155. Karaciğer Fibrozisinde Yeni Non İnvaziv Yöntem ELF Test
DURUSOY S. S., ÖZDEMİR F. T., ÖZDOĞAN O. C., RAHMİ A., YILMAZ Y., YEĞİN E. G., et al.
32. Ulusal Gastroenteroloji Haftası, Türkiye, 25 - 29 Kasım 2015
2015
20156. "Normal" Serum ALT/AST Level in Turkish Population
Karasu Z., Tozun N., İDİLMAN R., ÖZDOĞAN O. C., Kaymakoglu S., Cakaloglu Y., et al.
66th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), San-Francisco, Kostarika, 13 - 17 Kasım 2015, cilt.62, (Özet Bildiri)
2015
20157. Hepatitis C Seropositivity is not as high as Western Countries in the Population Born Between 1945-1965 According to Turkey Nationwide Hepatitis Prevalence Study (TURKHEP 2010)
ÖZDOĞAN O. C., Tozun N., Kaymakoglu S., İDİLMAN R., Karasu Z., AKARCA U. S.
66th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), San-Francisco, Kostarika, 13 - 17 Kasım 2015, cilt.62, (Özet Bildiri)
2014
20148. INFECTIONS WITH RESISTANT BACTERIA IN HOSPITALIZED CIRRHOTIC PATIENTS CAUSE LONGER HOSPITAL STAY AND FREQUENT ICU TRANSFER
Celik G., Koksal R., Bedir F., Ata G., Ozer M., Sancar S., et al.
49th Annual International Liver Congress of the European-Association-for-the-Study-of-the-Liver, London, Kanada, 9 - 13 Nisan 2014, cilt.60, (Özet Bildiri)
2014
20149. BENEFICIAL EFFECT OF MULTIDISCIPLINARY APPROACH ON SURVIVAL IN HEPATOCELLULAR CARCINOMA PATIENTS
Kani H. T., Siykhymbayev A., Demircan N., Banzragch M., Yegin E. G., Bicakci E., et al.
49th Annual International Liver Congress of the European-Association-for-the-Study-of-the-Liver, London, Kanada, 9 - 13 Nisan 2014, cilt.60, (Özet Bildiri)
2014
201410. Quantitative Assessment of Liver Fibrosis by Digital Image Analysis: Relationship to Ishak Staging and Elasticity by Shear-wave Elastography
Yegin E. G., YEĞİN K., Kombak F. E., Karatay E., TÜNEY D., Celikel Ç., et al.
65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Massachusetts, Amerika Birleşik Devletleri, 7 - 11 Kasım 2014, cilt.60, (Özet Bildiri)
2013
201311. Distribution of Natural Killer Cells in Liver Biopsies from Patients with Chronic Hepatitis C and Chronic Hepatitis B
Ahishali E., Banzragch M., Kombak F. E., ÖZKAN N., Yegin E. G., Dolapcioglu C., et al.
64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, Kiribati, 1 - 05 Kasım 2013, cilt.58, (Özet Bildiri)
2013
201312. SERUM ENDOSTATIN LEVEL IS ASSOCIATED WITH POOR SURVIVAL IN PATIENTS WITH ADVANCED STAGES OF HEPATOCELLULAR CARCINOMA
Yegin E., Syikymbayev A., Ozdogan O. C.
International Liver Congress / 48th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Amsterdam, Hollanda, 24 - 28 Nisan 2013, cilt.58, (Özet Bildiri)
2010
201013. A NATIONWIDE PREVALENCE STUDY AND RISK FACTORS FOR HEPATITIS A, B, C AND D INFECTIONS IN TURKEY
Tozun N., ÖZDOĞAN O. C., Cakaloglu Y., İDİLMAN R., Karasu Z., AKARCA U. S., et al.
61st Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Massachusetts, Amerika Birleşik Devletleri, 29 Ekim - 02 Kasım 2010, cilt.52, (Özet Bildiri)
2009
200914. MELATONIN AMELIORATES METHIONINE CHOLINE DEFICIENT DIET INDUCED NONALCOHOLIC STEATOHEPATITIS IN RATS
Tahan V., ATUĞ Ö., Akin H., EREN F., Tahan G., Tarcin Ö., et al.
60th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Massachusetts, Amerika Birleşik Devletleri, 30 Ekim - 03 Kasım 2009, cilt.50, (Özet Bildiri)
2006
200615. Lanreotid ve Peginterferon Alfa 28 tedavilerinin Koledok Ligasyon Yöntemi ile Oluşturulan Deneysel Karaciğer Fibrozu Üzerine Etkisi
TAHAN G., EREN F., TARÇIN O., TAHAN V., AKIN H., ŞAHİN H., et al.
23. Ulusal Gastroenteroloji Kongresi, İstanbul, Türkiye, 4 - 07 Kasım 2006
2006
200616. Siroz Hastalarında Hepatosellüler Karsinom Taramasında Altı Ayda Bir Yapılan Batın Ultrasonografi ve Serum Alfa-Feto Protein Ölçümüne Ek Olarak, Yılda Bir Kez Yapılan Batın Manyetik Rezonans Görüntülemesinin Erken Tanıya Olan Katkısı
BUĞDAYCI O., Sever A., DİLBER F., KEDRAH A. E., TİFTİKÇİ A., AKIN H., et al.
27. ULUSAL RADYOLOJİ KONGRESİ, Antalya, Türkiye, 11 - 15 Ekim 2006, (Özet Bildiri)
2005
200517. Role of ursodeoxycholic acid in the prevention of methotrexate induced liver toxicity
Uraz S., Tahan V., Aygun C., Eren F., Yuksel M., Unluguzel G., et al.
40th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Paris, Fransa, 13 - 17 Nisan 2005, cilt.42, ss.255, (Özet Bildiri)